Výsledky vyhľadávania - "Preclinical/methods"

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Zdroj: Genome Med
    Genome Medicine, Vol 16, Iss 1, Pp 1-15 (2024)
    Genome Medicine, vol 16, iss 1

    Popis súboru: application/pdf

  9. 9
  10. 10

    Zdroj: Mol Cancer Ther

    Popis súboru: application/pdf

  11. 11
  12. 12
  13. 13

    Autori: Bartfeld, Sina

    Zdroj: J Mol Med (Berl)

    Popis súboru: application/pdf

  14. 14
  15. 15

    Autori: Joye, T. Sidibé, J. Déglon, J. a ďalší

    Zdroj: Analytica chimica acta, Vol. 1063 (2019) pp. 110-116
    Analytica chimica acta, vol. 1063, pp. 110-116

    Popis súboru: application/pdf

  16. 16
  17. 17

    Zdroj: Leukemia

    Predmety: Pyridones, Drug Evaluation, Preclinical, Antineoplastic Agents, Pyrimidinones, Leukemia, Myelomonocytic, Chronic/pathology [MeSH], Antineoplastic Agents/adverse effects [MeSH], Drug Evaluation, Preclinical/standards [MeSH], Pyridones/pharmacology [MeSH], Drug Synergism [MeSH], Antineoplastic Agents/administration, Antineoplastic Agents/pharmacology [MeSH], Oncogenesis, Receptor, Notch1/genetics [MeSH], Translational research, Pyridones/therapeutic use [MeSH], Leukemia, Myelomonocytic, Chronic/genetics [MeSH], RNA, Small Interfering/genetics [MeSH], Disease Models, Animal [MeSH], Xenograft Model Antitumor Assays/methods [MeSH], Membrane Proteins/genetics [MeSH], Female [MeSH], Clonal Evolution [MeSH], Mutation [MeSH], Leukemia, Myelomonocytic, Chronic/drug therapy [MeSH], Protein Kinase Inhibitors/pharmacology [MeSH], Pyrimidinones/pharmacology [MeSH], Humans [MeSH], Azacitidine/pharmacology [MeSH], Leukemia, Myelomonocytic, Chronic/mortality [MeSH], Animals [MeSH], Protein Kinase Inhibitors/therapeutic use [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Antineoplastic Combined Chemotherapy Protocols/adverse effects [MeSH], Mice [MeSH], Article, Drug Evaluation, Preclinical/methods [MeSH], Preclinical research, Pyrimidinones/therapeutic use [MeSH], GTP Phosphohydrolases/genetics [MeSH], GTP Phosphohydrolases, Clonal Evolution, Mice, Antineoplastic Combined Chemotherapy Protocols, Animals, Humans, RNA, Small Interfering, Receptor, Notch1, Protein Kinase Inhibitors, ddc:610, Membrane Proteins, Drug Synergism, Leukemia, Myelomonocytic, Chronic, 3. Good health, Disease Models, Animal, Mutation, Azacitidine, Female

    Popis súboru: application/pdf

  18. 18

    Zdroj: Arch Toxicol
    Archives of Toxicology

    Popis súboru: application/pdf

  19. 19

    Prispievatelia: Lukas, Marina Velten, Britta Sellner, Leopold a ďalší

    Zdroj: Leukemia

    Predmety: Proto-Oncogene Proteins c-bcl-2/antagonists, Cell Line, Tumor [MeSH], Antineoplastic Agents/adverse effects [MeSH], Chronic lymphocytic leukaemia, Drug Evaluation, Preclinical/standards [MeSH], Drug Synergism [MeSH], Antineoplastic Agents/administration, Antineoplastic Agents/pharmacology [MeSH], Translational research, High-Throughput Nucleotide Sequencing/standards [MeSH], Receptors, Antigen, B-Cell/genetics [MeSH], Receptors, Antigen, B-Cell/metabolism [MeSH], Drug Resistance, Neoplasm/genetics [MeSH], Biomarkers, Tumor [MeSH], Proto-Oncogene Proteins c-bcl-2/genetics [MeSH], Combination drug therapy, Primary Cell Culture [MeSH], Dose-Response Relationship, Drug [MeSH], High-Throughput Nucleotide Sequencing/methods [MeSH], Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis [MeSH], Protein Kinase Inhibitors/pharmacology [MeSH], Humans [MeSH], Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy [MeSH], Protein Kinase Inhibitors/therapeutic use [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Antineoplastic Combined Chemotherapy Protocols/adverse effects [MeSH], Article, Drug Evaluation, Preclinical/methods [MeSH], Leukemia, Lymphocytic, Chronic, B-Cell/genetics [MeSH], Preclinical research, Proto-Oncogene Proteins c-bcl-2/metabolism [MeSH], Reproducibility of Results [MeSH], Receptors, Antigen, B-Cell/antagonists, 0301 basic medicine, 2720 Hematology, Primary Cell Culture, Drug Evaluation, Preclinical, Receptors, Antigen, B-Cell, 610 Medicine & health, Antineoplastic Agents, 03 medical and health sciences, Cell Line, Tumor, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Humans, 1306 Cancer Research, Protein Kinase Inhibitors, 0303 health sciences, Dose-Response Relationship, Drug, High-Throughput Nucleotide Sequencing, Reproducibility of Results, Drug Synergism, Leukemia, Lymphocytic, Chronic, B-Cell, ddc, 3. Good health, Proto-Oncogene Proteins c-bcl-2, Drug Resistance, Neoplasm, 10032 Clinic for Oncology and Hematology, 2730 Oncology

    Popis súboru: application/pdf

  20. 20